U.S. patent application number 16/041917 was filed with the patent office on 2018-11-29 for smart sensor ports and methods of using same.
This patent application is currently assigned to Abbott Diabetes Care Inc.. The applicant listed for this patent is Abbott Diabetes Care Inc.. Invention is credited to Benjamin J. Feldman, Benjamin M. Rush, Yi Wang.
Application Number | 20180339104 16/041917 |
Document ID | / |
Family ID | 42991150 |
Filed Date | 2018-11-29 |
United States Patent
Application |
20180339104 |
Kind Code |
A1 |
Wang; Yi ; et al. |
November 29, 2018 |
SMART SENSOR PORTS AND METHODS OF USING SAME
Abstract
The present disclosure provides an orientation-nonspecific
sensor port for use in analyte meters designed to detect and
quantify analyte levels in a fluid sample along with methods of
using the same. The present disclosure also provides compositions
and methods for facilitating the correct insertion of a sensor into
a corresponding analyte meter.
Inventors: |
Wang; Yi; (San Ramon,
CA) ; Feldman; Benjamin J.; (Berkeley, CA) ;
Rush; Benjamin M.; (Oakland, CA) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Abbott Diabetes Care Inc. |
Alameda |
CA |
US |
|
|
Assignee: |
Abbott Diabetes Care Inc.
Alameda
CA
|
Family ID: |
42991150 |
Appl. No.: |
16/041917 |
Filed: |
July 23, 2018 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
15294417 |
Oct 14, 2016 |
10058653 |
|
|
16041917 |
|
|
|
|
14868055 |
Sep 28, 2015 |
9494546 |
|
|
15294417 |
|
|
|
|
14312497 |
Jun 23, 2014 |
9207201 |
|
|
14868055 |
|
|
|
|
12644487 |
Dec 22, 2009 |
8771486 |
|
|
14312497 |
|
|
|
|
12431672 |
Apr 28, 2009 |
8758583 |
|
|
12644487 |
|
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
G01N 33/48707 20130101;
G01N 27/3273 20130101; G01N 27/48 20130101; A61M 5/1723
20130101 |
International
Class: |
A61M 5/172 20060101
A61M005/172; G01N 27/48 20060101 G01N027/48; G01N 33/487 20060101
G01N033/487; G01N 27/327 20060101 G01N027/327 |
Claims
1. A device comprising: a housing; a controller unit coupled to the
housing, the controller unit configured to: process a signal
received from an analyte sensor associated with an analyte;
determine a concentration of the analyte based on the signal
received; generate a command to query a user whether to perform a
medication dosage calculation; determine, based on the user query,
whether to perform the medication dosage calculation or whether not
to perform the medication dosage calculation; and automatically
enter into a medication dosage determination mode if the medication
dosage calculation is to be performed.
2. The device of claim 1, wherein the medication dosage calculation
is a bolus-type calculation, the bolus calculation being at least
one of a single-dose bolus, a correction bolus, a dual bolus, an
extended bolus, and a square wave bolus.
3. The device of claim 2, wherein the bolus calculation is at least
one of an insulin bolus calculation and a carbohydrate bolus
calculation.
4. The device of claim 1, further comprising a display unit coupled
to the housing, wherein the control unit is configured to display
on the display unit at least one of the concentration of the
analyte and the command to query the user whether to perform the
medication dosage calculation.
5. The device of claim 4, wherein the display unit is a
touch-screen.
6. The device of claim 1, further comprising an input unit coupled
to the housing, wherein the control unit is configured to allow the
user, based on the user query, to select whether to perform the
medication dosage calculation or whether not to perform the
medication dosage calculation using the input unit.
7. The device of claim 1, wherein the analyte sensor is a
continuous analyte monitoring sensor.
8. The device of claim 1, wherein the device is a continuous
analyte monitoring device.
9. The device of claim 1, further comprising an integrated
medication delivery device for administering a medication dosage
amount.
10. A device comprising: a housing; a controller unit coupled to
the housing, the controller unit configured to: process a signal
received from an analyte sensor associated with an analyte;
determine a concentration of the analyte based on the signal
received; generate a first command to query a user whether to
perform a medication dosage calculation; determine, based on the
first user query, whether to perform the medication dosage
calculation or whether not to perform the medication dosage
calculation; automatically enter into a medication dosage
determination mode if the medication dosage calculation is to be
performed, wherein the controller unit is configured in the
medication dosage determination mode to: generate a second command
to query the user of a type of medication dosage calculation to be
performed; execute, based on the second user query, a calculation
routine associated with the type of medication calculation to be
performed; and determine, based on the calculation routine, a
medication dosage amount.
11. The device of claim 10, wherein the medication dosage
calculation is a bolus-type calculation, the bolus calculation
being at least one of a single-dose bolus, a correction bolus, a
dual bolus, an extended bolus, and a square wave bolus.
12. The device of claim 11, wherein the bolus calculation is at
least one of an insulin bolus calculation and a carbohydrate bolus
calculation.
13. The device of claim 10, further comprising a display unit
coupled to the housing, wherein the control unit is configured to
display on the display unit at least one of the concentration of
the analyte, the first command to query the user whether to perform
the medication dosage calculation, the second command to query the
user of the type of medication dosage calculation to be performed,
and the medication dosage amount.
14. The device of claim 10, further comprising an input unit
coupled to the housing, wherein the control unit is configured to
allow the user, based on the first user query, to select whether to
perform the medication dosage calculation or whether not to perform
the medication dosage calculation using the input unit; and to
allow the user, based on the second user query, to select the type
of medication dosage calculation to be performed using the input
unit.
15. The device of claim 10, further comprising a data storage unit
coupled to the housing, wherein the calculation routine is stored
in the data storage unit and the control unit is configured to
retrieve the calculation routine from the data storage unit.
16. The device of claim 10, wherein the control unit is configured
to generate at least a third command to query the user for
information required to execute the calculation routine.
17. The device of claim 16, wherein the third user query is at
least one of an estimate of carbohydrate amount, an insulin
sensitivity value, and an insulin on board information.
18. The device of claim 10, wherein the analyte sensor is a
continuous analyte monitoring sensor.
19. The device of claim 10, wherein the device is a continuous
analyte monitoring device.
20. The device of claim 10, further comprising an integrated
medication delivery device for administering the medication dosage
amount.
Description
BACKGROUND
[0001] Analytical sensors and meters are often used in chemistry
and medicine to determine the presence and/or concentration of a
biological analyte of interest. For example, such analytical
sensors and meters are used to monitor glucose in diabetic patients
and lactate during critical care events.
[0002] Many currently available analyte meters are configured such
that a sensor is inserted into the analyte meter during the testing
process. Such meters are orientation specific in that they require
that the corresponding sensor is inserted in a specific orientation
which allows for detection of a signal from the sensor and
measurement of analyte concentration. This orientation requirement
complicates the testing process and, in the context of diabetes
care, makes it more difficult for certified diabetes educators to
teach the correct use of the devices. This problem may be
compounded when the patient is a young child or suffers from
impaired vision.
[0003] It would therefore be desirable and useful to develop an
orientation non-specific analyte meter, capable of performing an
accurate and sensitive analysis of the concentration of analytes in
a liquid sample.
SUMMARY OF THE INVENTION
[0004] The present disclosure provides orientation-nonspecific
sensor ports for use in analyte meters designed to detect and
quantify analyte levels in a fluid sample along with methods of
using the same. The present disclosure also provides compositions
and methods for facilitating the correct insertion of a sensor into
a corresponding analyte meter. These and other objects, features
and advantages of the present disclosure will become more fully
apparent from the following detailed description of the
embodiments, the appended claims and the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
[0005] Referring now to the drawings, wherein like reference
numerals and letters indicate corresponding structure throughout
the several views:
[0006] FIG. 1 shows a first embodiment of an analyte meter
according the present disclosure;
[0007] FIG. 2 shows an exploded view of an analyte sensor which is
configured such that it can be inserted in two effective
orientations into the analyte meter shown in FIG. 1;
[0008] FIG. 3 shows a second embodiment of an analyte meter
according to the present disclosure;
[0009] FIG. 4 shows an exploded view of an analyte sensor which is
configured such that it can be inserted in two effective
orientations into the analyte meter shown in FIG. 3 or FIG. 5;
[0010] FIG. 5 shows a third embodiment of an analyte meter
according to the present disclosure;
[0011] FIG. 6 shows an exploded view (A) and a top view (B) of an
analyte sensor which is configured such that it can be inserted in
two effective orientations into the analyte meter shown in FIG.
5;
[0012] FIG. 7 shows a fourth embodiment of an analyte meter
according to the present disclosure;
[0013] FIG. 8 shows an exploded view (A) and a top view (B) of an
analyte sensor which is configured such that it can be inserted in
two effective orientations into the analyte meter shown in FIG.
7;
[0014] FIG. 9 shows three (A-C) exemplary demarcation schemes
according to the present disclosure;
[0015] FIG. 10 is a flow chart showing an analyte concentration
determination and medication dose calculation procedure in
accordance with an embodiment of the present disclosure;
[0016] FIG. 11 is a flow chart illustrating the medication dose
calculation procedure of FIG. 10; and
[0017] FIG. 12 is a flow chart showing an analyte concentration
determination and medication dose calculation procedure in
accordance with an alternative embodiment of the present
disclosure.
[0018] Before the present invention is further described, it is to
be understood that this invention is not limited to particular
embodiments described, as such may, of course, vary. It is also to
be understood that the terminology used herein is for the purpose
of describing particular embodiments only, and is not intended to
be limiting, since the scope of the present invention will be
limited only by the appended claims.
[0019] Where a range of values is provided, it is understood that
each intervening value, to the tenth of the unit of the lower limit
unless the context clearly dictates otherwise, between the upper
and lower limit of that range and any other stated or intervening
value in that stated range, is encompassed within the invention.
The upper and lower limits of these smaller ranges may
independently be included in the smaller ranges, and are also
encompassed within the invention, subject to any specifically
excluded limit in the stated range. Where the stated range includes
one or both of the limits, ranges excluding either or both of those
included limits are also included in the invention.
[0020] Unless defined otherwise, all technical and scientific terms
used herein have the same meaning as commonly understood by one of
ordinary skill in the art to which this invention belongs. Although
any methods and materials similar or equivalent to those described
herein can also be used in the practice or testing of the present
invention, the preferred methods and materials are now described.
All publications mentioned herein are incorporated herein by
reference to disclose and describe the methods and/or materials in
connection with which the publications are cited.
[0021] As used herein and in the appended claims, the singular
forms "a," "and," and "the" include plural referents unless the
context clearly dictates otherwise. It is further noted that the
claims may be drafted to exclude any optional element. As such,
this statement is intended to serve as antecedent basis for use of
such exclusive terminology as "solely," "only" and the like in
connection with the recitation of claim elements, or use of a
"negative" limitation.
[0022] The publications discussed herein are provided solely for
their disclosure prior to the filing date of the present
application. Nothing herein is to be construed as an admission that
the present invention is not entitled to antedate such publication
by virtue of prior invention. Further, the dates of publication
provided may be different from the actual publication dates which
may need to be independently confirmed.
DETAILED DESCRIPTION
Analyte Meters
[0023] The present disclosure provides analyte meters designed to
receive analyte sensors. The analyte meters are configured to
process a signal received from the analyte sensor and determine a
concentration of analyte based on the received signal. In some
embodiments, the analyte meters are specifically designed to
receive an analyte sensor in an orientation non-specific manner
making it easier for a user to operate the analyte meter and the
corresponding sensor.
[0024] The analyte meters may be small portable devices designed to
be palm-sized and/or adapted to fit into, for example, a pocket or
purse of a patient. The analyte meter may have the appearance of a
personal electronic device, such as a mobile phone or personal
digital assistant (PDA), so that the user may not be identified as
a person using a medical device. Additional information is provided
in U.S. Pat. No. 7,041,468, titled "Blood Glucose Tracking
Apparatus and Method" and in U.S. Patent Application Publication
No. US2004/0254434, published Dec. 16, 2004, titled "Glucose
Measuring Module and Insulin Pump Combination", the disclosures of
each of which are incorporated by reference herein.
[0025] In embodiments, the analyte meters may be a larger unit for
home use and designed to sit on a shelf or nightstand. In yet other
embodiments, the analyte meters may be designed for use in a
hospital or doctor's office.
Analyte Meter Configured to Receive Analyte Sensor Having an
Opposing Electrode Configuration
[0026] In one embodiment, as illustrated in FIG. 1, analyte meter
100 includes a housing 105 and a sensor port 101 coupled to the
housing 105, wherein the sensor port 101 is configured to receive
an analyte sensor 200 as shown in FIG. 2. Sensor port 101 includes
a first electrode contact 103 and a second electrode contact 104
positioned on opposing faces of sensor port 101. Although electrode
contact 103 is designated as the first electrode contact, and
electrode contact 104 is designated as the second electrode
contact, it should be noted that these designations can be
reversed. That is, the electrode contact indicated by reference
numeral 104 can be the first electrode contact, and the electrode
contact indicated by reference numeral 103 can be the second
electrode contact.
[0027] Each of the first electrode contact 103 and the second
electrode contact 104 is capable of being configured as a working
electrode contact. Analyte meter 100 is configured to detect an
insertion orientation of analyte sensor 200 upon insertion of
analyte sensor 200 into sensor port 101. Based on the detected
insertion orientation, analyte meter 100 configures one of first
electrode contact 103 and second electrode contact 104 as a working
electrode contact. As described in greater detail below, this
capability of the analyte meter allows the user of the analyte
meter to insert an analyte sensor in either of two effective
insertion orientations.
[0028] In order to facilitate detection of the insertion
orientation of analyte sensor 200, sensor port 101 can optionally
be configured to include a first turn-on/selection contact 102A and
a second turn-on/selection contact 102B. In the embodiment shown in
FIG. 1, these optional turn-on/selection contacts are positioned on
opposing faces of sensor port 101, although additional
configurations are possible. In one embodiment, as shown in FIG. 1,
each of turn-on/selection contacts 102A and 102B includes a pair of
conductive strips. This configuration is merely exemplary, and many
other configurations including single turn-on/selection contacts
are feasible.
[0029] In one embodiment, each of first electrode contact 103 and
second electrode contact 104 is capable of being configured as a
reference and/or counter electrode contact. In such an embodiment,
the analyte meter configures one of the electrode contacts as a
working electrode contact (e.g., 103) and the other (e.g., 104) as
a reference and/or counter electrode contact based on the insertion
orientation of the analyte sensor.
[0030] In one embodiment, when analyte meter 100 includes optional
turn-on/selection contacts 102A and 102B, analyte meter 100 is
activated for testing by contacting first turn-on/selection contact
102A or second turn-on/selection contact 102B with analyte sensor
200 upon insertion of analyte sensor 200 into sensor port 101.
Analyte meter 100 configures one of first electrode contact 103 and
second electrode contact 104 as a working electrode contact and one
of first electrode contact 103 and second electrode contact 104 as
a reference and/or counter electrode contact based on the
contacting of first turn-on/selection contact 102A or second
turn-on/selection contact 102B with analyte sensor 200. This allows
analyte meter 100 to accept an analyte sensor 200 in either a
"face-up" or "face-down" orientation. For example, with reference
to FIGS. 1 and 2, analyte sensor 200 can be inserted into sensor
port 101 such that working electrode 203 contacts first electrode
contact 103. In this orientation, reference and/or counter
electrode 204 contacts second electrode contact 104. This insertion
orientation is considered a face-up orientation. In a face-down
orientation, analyte sensor 200 is inserted such that working
electrode 203 contacts second electrode contact 104 and reference
and/or counter electrode 204 contacts first electrode contact
103.
[0031] FIG. 3 illustrates an embodiment of analyte meter 100,
wherein analyte meter 100 is configured to receive an analyte
sensor using a four-electrode system having opposing working and
reference and/or counter electrodes. Analyte sensors of this type
are available from Abbott Diabetes Care Inc., Alameda, Calif. and
include FreeStyle.RTM. and FreeStyle Lite.TM. test strips.
[0032] As shown in FIG. 3, in one embodiment, an analyte meter 100
according to the present disclosure includes a first set of
electrode contacts, including electrode contacts 103A, 103B and
103C; and a second set of electrode contacts, including 104A, 104B
and 104C. At least one of electrode contacts 103A, 103B and 103C is
capable of being configured as a working electrode contact and at
least one of electrode contacts 104A, 104B and 104C is capable of
being configured as a working electrode contact.
[0033] The analyte meter 100 shown in FIG. 3 is configured to
receive an analyte sensor such as analyte sensor 200 shown in FIG.
4. In order to facilitate detection of the insertion orientation of
analyte sensor 200, sensor port 101 can optionally be configured to
include a first turn-on/selection contact 102A and a second
turn-on/selection contact 102B. In the embodiment shown in FIG. 3,
these optional turn-on/selection contacts are positioned on
opposing faces of sensor port 101, although additional
configurations are possible. In one embodiment, as shown in FIG. 3,
each of turn-on/selection contacts 102A and 102B includes a pair of
conductive strips. As indicated above for FIG. 1, this
configuration is merely exemplary, and many other configurations
including single turn-on/selection contacts are feasible.
[0034] In one embodiment, when analyte meter 100 includes optional
turn-on/selection contacts 102A and 102B, analyte meter 100 is
activated for testing by contacting first turn-on/selection contact
102A or second turn-on/selection contact 102B with analyte sensor
200 upon insertion of analyte sensor 200 into sensor port 101. As
in FIG. 1, the analyte meter 100 shown in FIG. 3 is capable
receiving analyte sensor 200 in a "face-up" or "face-down"
insertion orientation. For example, with reference to FIGS. 3 and
4, analyte sensor 200 can be inserted into sensor port 101 such
that working electrode 203 contacts electrode contact 103A. In this
orientation, reference and/or counter electrode 204 contacts
electrode contact 104B and indicator electrodes 208 and 209 contact
electrode contacts 104A and 104C respectively. This insertion
orientation is considered a face-up orientation. In such an
orientation, electrode contacts 103C and 103B are inactive. In a
face-down orientation, analyte sensor 200 is inserted such that
working electrode 203 contacts electrode contact 104A. In this
orientation, reference and/or counter electrode 204 contacts
electrode contact 103B and indicator electrodes 208 and 209 contact
electrode contacts 103A and 103C respectively. In such an
orientation, electrode contacts 104B and 104C are inactive.
[0035] In the embodiment shown in FIG. 3, a first set of electrode
contacts (103A-103C) are offset relative to a second set of
electrode contacts (104A-104C) on opposing faces of sensor port
101. In another embodiment, as shown in FIG. 5, an analyte meter
100 includes a sensor port 101 which includes a first set of
contacts (103A-103D) positioned directly across from a second set
of electrode contacts (104A-104D) on opposing faces of sensor port
101. As indicated above, a sensor 200 as shown in FIG. 4 can be
effectively inserted in either of two insertion orientations into
an analyte meter 100 as shown in FIG. 3. An analyte meter 200 as
shown in FIG. 4 can also be effectively inserted in either of two
insertion orientations into an analyte meter 100 as shown in FIG.
5. In such an embodiment, in a face-up orientation, working
electrode 203 contacts electrode contact 103A, reference and/or
counter electrode 204 contacts electrode contact 104B, indicator
electrodes 208 and 209 contact electrode contacts 104A and 104C
respectively, and electrode contacts 103B, 103C, 103D and 104D are
inactive. In a face-down orientation, working electrode 203
contacts electrode contact 104A, reference and/or counter electrode
204 contacts electrode contact 103B, indicator electrodes 208 and
209 contact electrode contacts 103A and 103C respectively, and
electrode contacts 103D, 104B, 104C and 104D are inactive.
Analyte Meter Configured to Receive Analyte Sensor Having a
Coplanar Electrode Configuration
[0036] The embodiments described above are directed to analyte
meters configured to receive analyte sensors having a working
electrode positioned in opposition to a reference and/or counter
electrode, e.g., as shown in FIGS. 2 and 4. In another embodiment,
analyte meters according to the present disclosure are configured
to receive analyte sensors having a working electrode and a
reference and/or counter electrode positioned in a coplanar
configuration. An example of such a coplanar configuration is
provided in FIG. 6, wherein electrodes 203, 204, 208 and 209 are
positioned in the same lateral plane on substrate 201.
[0037] The analyte meter 100 shown in FIG. 5 is configured to
receive an analyte sensor such as analyte sensor 200 shown in FIG.
6. In order to facilitate detection of the insertion orientation of
analyte sensor 200, sensor port 101 can optionally be configured to
include a first turn-on/selection contact 102A and a second
turn-on/selection contact 102B. In the embodiment shown in FIG. 5,
these optional turn-on/selection contacts are positioned on
opposing faces of sensor port 101, although additional
configurations are possible. In one embodiment, as shown in FIG. 5,
each of turn-on/selection contacts 102A and 102B includes a pair of
conductive strips. This configuration is merely exemplary, and many
other configurations including single turn-on/selection contacts
are feasible.
[0038] In one embodiment, when analyte meter 100 includes optional
turn-on/selection contacts 102A and 102B, analyte meter 100 is
activated for testing by contacting first turn-on/selection contact
102A or second turn-on/selection contact 102B with analyte sensor
200 upon insertion of analyte sensor 200 into sensor port 101. As
in FIGS. 1 and 3, analyte meter 100 shown in FIG. 5 is capable
receiving analyte sensor 200 in a "face-up" or "face-down"
insertion orientation. For example, with reference to FIGS. 5 and
6, analyte sensor 200 can be inserted into sensor port 101 such
that working electrode 203 contacts electrode contact 103B. In this
orientation, reference and/or counter electrode 204 contacts
electrode contact 103C and indicator electrodes 208 and 209 contact
electrode contacts 103A and 103D respectively. This insertion
orientation is considered a face-up orientation. In such an
orientation, electrode contacts 104A, 104B, 104C and 104D are
inactive. In a face-down orientation, analyte sensor 200 is
inserted such that working electrode 203 contacts electrode contact
104B. In this orientation, reference and/or counter electrode 204
contacts electrode contact 104C and indicator electrodes 208 and
209 contact electrode contacts 104A and 104D respectively. In such
an orientation electrode contacts 103A, 103B, 103C and 103D are
inactive.
[0039] An additional example of a coplanar electrode configuration
is provided in FIG. 8, wherein electrodes 203, 204, and 212 are
positioned in the same lateral plane on substrate 201.
[0040] The analyte meter 100 shown in FIG. 7 is configured to
receive an analyte sensor such as analyte sensor 200 shown in FIG.
8. In order to facilitate detection of the insertion orientation of
analyte sensor 200, sensor port 101 can optionally be configured to
include a first turn-on/selection contact 102A and a second
turn-on/selection contact 102B. In the embodiment shown in FIG. 7,
these optional turn-on/selection contacts are positioned on
opposing faces of sensor port 101, although additional
configurations are possible. In one embodiment, as shown in FIG. 7,
each of turn-on/selection contacts 102A and 102B includes a pair of
conductive strips. This configuration is merely exemplary, and many
other configurations including single turn-on/selection contacts
are feasible.
[0041] In one embodiment, when analyte meter 100 includes optional
turn-on/selection contacts 102A and 102B, analyte meter 100 is
activated for testing by contacting first turn-on/selection contact
102A or second turn-on/selection contact 102B with analyte sensor
200 upon insertion of analyte sensor 200 into sensor port 101. As
in FIGS. 1, 3, and 5 analyte meter 100 shown in FIG. 7 is capable
receiving analyte sensor 200 in a "face-up" or "face-down"
insertion orientation. For example, with reference to FIGS. 7 and
8, analyte sensor 200 can be inserted into sensor port 101 such
that working electrode 203 contacts electrode contact 103C. In this
orientation, reference and/or counter electrode 204 contacts
electrode contact 103A and indicator electrode 212 contacts
electrode contact 103B. This insertion orientation is considered a
face-up orientation. In such an orientation, electrode contacts
104A, 104B, and 104C are inactive. In a face-down orientation,
analyte sensor 200 is inserted such that working electrode 203
contacts electrode contact 104C. In this orientation, reference
and/or counter electrode 204 contacts electrode contact 104A and
indicator electrode 212 contacts electrode contact 104B. In such an
orientation electrode contacts 103A, 103B, and 103C are
inactive.
[0042] Additional sensors having coplanar electrode configurations
are described in U.S. patent application Ser. No. 12/102,374, filed
Apr. 14, 2008, and U.S. Patent Application Publication No.
2009/0095625, the disclosures of each of which are incorporated by
reference herein.
Analyte Sensors
[0043] Referring to the Drawings in general and FIGS. 2, 4, 6 and 8
in particular, the an analyte sensor 200 described herein generally
includes a first substrate 201, a spacer 205, a second substrate
202, a working electrode 203, a reference and/or counter electrode
or reference/counter electrode 204, and a measurement zone defined
at least in part by working electrode 203, reference and/or counter
electrode 204 and one or more of substrate 201, substrate 202 and
spacer 205. As used herein, the term "reference and/or counter
electrode" refers to an electrode that functions as a reference
electrode, a counter electrode or a reference/counter electrode.
The measurement zone is configured such that when a sample is
provided in the measurement zone the sample is in electrolytic
contact with the working electrode 203 and the reference and/or
counter electrode and/or reference/counter electrode 204. As shown
in FIG. 6, analyte sensor 200 generally includes a proximal end 210
for insertion into analyte meter 100 and a distal end 211 for
receiving a liquid sample.
[0044] In certain embodiments, an analyte sensor has a generally
rectangular shape, i.e., the sensor's length is greater than its
width, although other shapes are possible as well. In one
embodiment, the analyte sensor is in the form of a strip.
[0045] Analyte sensors suitable for use with the analyte meters
described herein can include a plurality of electrodes, e.g., 2, 3,
or 4 or more electrodes.
[0046] In addition to the embodiments specifically disclosed
herein, the analyte meters of the present disclosure can be
configured to work with a wide variety of analyte sensors, e.g.,
those disclosed in U.S. patent application Ser. No. 11/461,725,
filed Aug. 1, 2006; U.S. Patent Application Publication No.
2007/0095661; U.S. Patent Application Publication No. 2006/0091006;
U.S. Patent Application Publication No. 2006/0025662; U.S. Patent
Application Publication No. 2008/0267823; U.S. Patent Application
Publication No. 2007/0108048; U.S. Patent Application Publication
No. 2008/0102441; U.S. Patent Application Publication No.
2008/0066305; U.S. Patent Application Publication No. 2007/0199818;
U.S. Patent Application Publication No. 2008/0148873; U.S. Patent
Application Publication No. 2007/0068807; U.S. Pat. No. 6,616,819;
U.S. Pat. No. 6,143,164; and U.S. Pat. No. 6,592,745; the
disclosures of each of which are incorporated by reference
herein.
Fill Indicator Detection
[0047] As discussed previously herein, analyte sensor 200 can
include one or more indicator electrodes. Such indicator electrodes
are well known in the art and can be used to indicate when a
measurement zone of analyte sensor 200 is filled with sample.
Accordingly, in some embodiments, analyte meter 100 is configured
to detect a signal from the indicator electrode in addition to
signals from the working electrode 203 and/or reference and/or
counter electrode 204.
[0048] Suitable signals for detection include, for example,
voltage, current, resistance, impedance, or capacitance between the
indicator electrode and, for example, working electrode 203.
Alternatively, the analyte meter 100 can be configured to detect if
a value of the signal (e.g., voltage, current, resistance,
impedance, or capacitance) received from analyte sensor 200 has
been reached indicating that the measurement zone is filled.
[0049] Analyte meter 100 can include a sign (e.g., a visual sign or
auditory signal) that is activated in response to the indicator
electrode to alert the user that the measurement zone has been
filled. The controller unit of analyte meter 100 can be configured
to initiate a reading when the indicator electrode indicates that
the measurement zone has been filled with or without alerting the
user. The reading can be initiated, for example, by applying a
potential between the working electrode and the reference and/or
counter electrode and beginning to monitor the signals generated at
the working electrode. Additional description of indicator
electrodes and fill-detection can be found in U.S. Pat. No.
6,592,745, the disclosure of which is incorporated by reference
herein.
Turn-On/Selection Monitor
[0050] In some embodiments, analyte meter 100 is configured to
receive an analyte sensor 200 which includes an optional
turn-on/selection monitor 206 as shown in FIGS. 2, 4, 6 and 8. The
turn-on/selection monitor 206 is configured to facilitate certain
functions of analyte meter 100. For example in one embodiment,
turn-on/selection monitor 206 is designed to facilitate detection
of analyte sensor 200 by analyte meter 100 upon insertion of
analyte sensor 200 into sensor port 101. In one embodiment, such
detection results in activation of analyte meter 100 for testing,
i.e., turn-on/selection monitor 206 facilitates a "turn-on"
function of analyte meter 100. In another embodiment, such
detection results in the analyte meter selecting a particular
electrode contact (e.g. one of two available electrode contacts) as
a working electrode contact, i.e., turn-on/selection monitor 206
facilitates a "selection" function of analyte meter 100.
[0051] In the context of the embodiment shown in FIGS. 1, 3, 5 and
7, optional turn-on/selection monitor 206 is designed to contact
either first turn-on/selection contact 102A or second
turn-on/selection contact 102B upon insertion of analyte sensor
200.
[0052] In some embodiments, detection of the analyte sensor is
accomplished electrically. For example, the turn-on/selection
monitor 206 can be configured to close or open an electrical
circuit when the sensor is inserted into the analyte meter. In some
embodiments, closing or opening the electrical circuit in turn
activates the analyte meter for testing. The turn-on/selection
monitor 206 can include a conductive material which facilitates
electronic detection of analyte sensor 200. For example, in the
embodiment shown in FIGS. 2, 4, 6 and 8, turn-on/selection monitor
206 comprises conductive material is in the form of a conductive
strip extending across an exterior surface of analyte sensor
200.
[0053] In one embodiment, turn-on/selection monitor 206 is designed
such that it physically opens or closes an electric circuit in an
analyte meter upon insertion. For example, turn-on/selection
monitor 206 could be designed as a dimple or a protrusion which
physically opens or closes an electronic circuit upon insertion of
the analyte sensor into the analyte meter.
[0054] In other embodiments, detection of the analyte sensor is
accomplished mechanically. For example, turn-on/selection monitor
206 can have a physical structure which engages with a
corresponding physical structure in sensor port 101, e.g., in a
"lock and key" type configuration. For example, turn-on/selection
monitor 206 can include a first physical structure configured to
engage with a second physical structure present in sensor port 101,
wherein the physical structure present on analyte sensor 200
includes at least one cutout and/or protrusion, wherein the shape,
dimensions and/or number of the at least one cutout and/or
protrusion engages with a corresponding physical structure in
sensor port 101. The forming of a particular cutout and/or
protrusion shape may be accomplished by several methods. For
example, the specific cutout and/or protrusion shape may be formed
by cutting to a desired shape. The cutting may be done, by, for
example, a laser such as a laser-ablation method. The sensor port
101 can be configured such that this physical interaction in turn
facilitates turn-on and/or selection functions of the analyte meter
100 as described above.
[0055] While the turn-on/selection contacts of FIGS. 1, 3, 5 and 7
are shown as pairs of conductive strips, it should be noted that a
variety of configurations are possible for the turn-on/selection
contacts, provided that, where the turn-on/selection contacts
facilitate a selection function of the analyte meter, the analyte
meter can determine which orientation (face-up or face-down) the
analyte sensor is in once inserted and select the electrode
contacts accordingly.
[0056] In one embodiment, where the analyte meter 100 is designed
to receive a sensor 200 having a two electrode configuration such
as that shown in FIG. 2, one of the electrode contacts is selected
as the working electrode contact the remaining electrode contact is
selected as the reference and/or counter electrode contact based on
the insertion orientation of sensor 200.
[0057] In one embodiment, insertion of the analyte sensor 200 into
a sensor port 101 of analyte meter 100 results in the completion of
a circuit when the turn-on/selection monitor 206 comes into contact
with a pair of turn-on/selection contacts.
[0058] In one particular embodiment, turn-on/selection monitor 206
is positioned at least substantially perpendicular to working
electrode 203 and reference and/or counter electrode 204. In
another embodiment, turn-on/selection monitor 206 is positioned at
least substantially parallel to working electrode 203 and reference
and/or counter electrode 204.
[0059] Turn-on/selection monitor 206 may have any suitable
configuration, including but not limited to, a stripe extending
across analyte sensor 200 from a side edge to a side edge, such as
the embodiment shown in FIGS. 2, 4, 6 and 8; a stripe extending
across the analyte sensor, although not the entire width; and an
array of unconnected dots, strips, or other areas. Other suitable
configurations for turn-on/selection monitor 206 are provided in
U.S. Patent Application Publication No. US2006/0091006; U.S. Patent
Application Publication No. US2008/0267823; U.S. Pat. No.
6,592,745; U.S. Pat. No. 6,143,164; U.S. Pat. No. 6,071,391; U.S.
Pat. No. 6,503,381; U.S. Pat. No. 6,616,819 and U.S. Pat. No.
6,893,545; the disclosures of each of which are incorporated by
reference herein.
Sensor Port
[0060] As described above, analyte meter 100 includes sensor port
101. It should be noted that while the figures depict both analyte
sensor 200 and corresponding sensor port 101 as having a
rectangular box shape, such configuration is for exemplary purposes
only and a variety of other configurations are possible. For
example, a cylindrical configuration could be used for both analyte
sensor 200 and sensor port 101.
[0061] In the embodiment shown in FIG. 1, sensor port 101 includes
first electrode contact 103 and second electrode contact 104. These
contacts can be made of the same or different material and any
suitable material, e.g., carbon, platinum, etc., can be used
provided that the material is sufficiently conductive to allow
transfer of an electrical signal from electrodes 203 and 204 of
analyte sensor 200.
[0062] A variety of configurations are possible for electrode
contacts 103 and 104, and these configurations can be modified
based on the selected configuration of electrodes 203 and 204 on
analyte sensor 200 and vice versa. In one embodiment, electrode
contacts 103 and 104 are positioned directly across from one
another on opposing faces of sensor port 101. In other embodiments,
electrode contacts 103 and 104 are not positioned directly across
from one another, but are instead offset on opposing faces of
sensor port 101. An example of an offset electrode contact
configuration is shown in FIG. 1. Notwithstanding the above,
electrode contacts 103 and 104 are positioned in the sensor port
such that one of electrode contacts 103 and 104 contacts working
electrode 103 and the other electrode contact contacts reference
and/or counter electrode 204 upon insertion of analyte sensor 200
into sensor port 101.
[0063] Sensor port 101 also includes first turn-on/selection
contact 102A and second turn-on/selection contact 102B positioned
on opposing faces of sensor port 101. These contacts can be made of
the same or different material and any suitable material can be
used. In some embodiments, the material is sufficiently conductive
to allow for completion of an electrical circuit when contacted by
a conductive turn-on/selection monitor.
[0064] A variety of configurations are possible for
turn-on/selection contacts 102A and 102B, and these configurations
can be modified based on the selected configuration of
turn-on/selection monitor 206 and vice versa. For example, in the
embodiments shown in FIGS. 1, 3, 5 and 7, each of turn-on/selection
contacts 102A and 102B is shown as a pair of conductive strips
positioned on the bottom and top faces respectively of sensor port
101.
[0065] Turn-on/selection contacts 102A and 102B can be positioned
to suit a particular sensor/meter configuration. In the embodiments
shown in FIGS. 1, 3, 5 and 7, turn-on/selection contacts 102A and
102B are positioned substantially parallel with insertion path 106
of analyte sensor 200. This orientation can be adjusted, e.g.,
depending on the orientation of turn-on/selection monitor 206 on
analyte sensor 200. For example, if turn-on/selection monitor 206
were positioned parallel to electrodes 203 and 204 of analyte
sensor 200 (rather than perpendicular as shown in FIGS. 2, 4, 6 and
8) it may be desirable to position turn-on/selection contacts 102A
and 102B substantially perpendicular to insertion path 106 in
sensor port 101. As indicated above, the configuration provided in
FIGS. 1, 3, 5 and 7 is merely exemplary, and many other
configurations including single turn-on/selection contacts are
feasible.
[0066] In some embodiments, analyte meter 100 is configured to
detect insertion of analyte sensor 200 mechanically. In such
embodiments, first turn-on/selection contact 102A and second
turn-on/selection contact 102B are configured accordingly. For
example, turn-on/selection contacts 102A and 102B could each be
designed as a pair of conductive strips, wherein the members of
each pair are in contact and part of a closed electrical circuit
when analyte sensor 200 is not inserted. The members of each pair
can be configured such that their contact is physically disruptable
upon insertion of an analyte sensor 200 having a turn-on/selection
monitor 206 with a specific physical structure, e.g. a raised
protrusion which physically separates a member of each pair of
conductive strips from the other member of the pair of conductive
strips. In this manner, one of turn-on/selection contacts 102A and
102B will be contacted and the analyte meter 100 can select a
particular electrode contact as the working electrode contact
accordingly.
[0067] In some embodiments, analyte meter 100 is configured to
detect insertion of analyte sensor 200 optically. In such
embodiments, first turn-on/selection contact 102A and second
turn-on/selection contact 102B are configured accordingly. For
example, turn-on/selection contacts 102A and 102B could each be
configured to include a photodetector, wherein the photodetector is
configured to detect a colored area on a face of the sensor.
Depending on the insertion orientation, one of turn-on/selection
contacts 102A and 102B will detect the colored area and the analyte
meter 100 can select a particular electrode contact as the working
electrode contact accordingly. A variety of photodetectors are
known in the art, including but not limited to photoconductive
cells, photodiodes, photoresistors, photoswitches,
phototransistors, phototubes, and photovoltaic cells. It is also
contemplated that optical means could be utilized to detect a
physical structure present on analyte sensor 200, e.g., a
particular shape and/or arrangement of cutouts and/or protrusions
present on analyte sensor 200, and that insertion orientation could
be detected accordingly.
[0068] In one embodiment, analyte meter 100 includes an optional
illumination device, e.g., a light emitting diode (LED), which may
be configured to illuminate the sensor port 101 during the analyte
sensor insertion process to assist the user in properly and
accurately inserting the analyte sensor 200 into sensor port 101.
In some embodiments, the optional illumination device facilitates
the optical detection of analyte sensor insertion orientation.
[0069] In a further embodiment of the present disclosure, the
sensor port 101 may be configured with a physical latch or
securement mechanism such that when the analyte sensor 200 is
inserted into the sensor port 101, the analyte sensor 200 is
retained in the received position within the sensor port 101 until
the sample analysis is completed. Examples of such physical latch
or securement mechanism may include a uni-directionally biased
anchor mechanism, or a pressure application mechanism to retain the
analyte sensor 200 in place by applying pressure on one or more
surfaces of the analyte sensor 200 within the sensor port 101.
Additional information is provided in U.S. Patent Application
Publication No. 2008/0119709, the disclosure of which is
incorporated by reference herein.
Controller Unit
[0070] Analyte meter 100 also includes a controller unit (not
shown) coupled to housing 105, wherein the controller unit is
configured to process a signal received from analyte sensor 200 and
determine the presence and/or concentration of the analyte based on
the signal.
[0071] The controller unit is configured to process a signal
received from analyte sensor 200 and determine a concentration of
analyte, e.g., glucose, based on the signal. Details relating to
the receipt of an analyte signal from an analyte sensor and the
determination of a concentration of analyte are described, for
example, in U.S. Pat. No. 7,041,468; U.S. Pat. No. 5,356,786; U.S.
Pat. No. 6,175,752; U.S. Pat. No. 6,560,471; U.S. Pat. No.
5,262,035; U.S. Pat. No. 6,881,551; U.S. Pat. No. 6,121,009; U.S.
Pat. No. 7,167,818; U.S. Pat. No. 6,270,455; U.S. Pat. No.
6,161,095; U.S. Pat. No. 5,918,603; U.S. Pat. No. 6,144,837; U.S.
Pat. No. 5,601,435; U.S. Pat. No. 5,822,715; U.S. Pat. No.
5,899,855; U.S. Pat. No. 6,071,391; U.S. Pat. No. 6,120,676; U.S.
Pat. No. 6,143,164; U.S. Pat. No. 6,299,757; U.S. Pat. No.
6,338,790; U.S. Pat. No. 6,377,894; U.S. Pat. No. 6,600,997; U.S.
Pat. No. 6,773,671; U.S. Pat. No. 6,514,460; U.S. Pat. No.
6,592,745; U.S. Pat. No. 5,628,890; U.S. Pat. No. 5,820,551; U.S.
Pat. No. 6,736,957; U.S. Pat. No. 4,545,382; U.S. Pat. No.
4,711,245; U.S. Pat. No. 5,509,410; U.S. Pat. No. 6,540,891; U.S.
Pat. No. 6,730,200; U.S. Pat. No. 6,764,581; U.S. Pat. No.
6,299,757; U.S. Pat. No. 6,461,496; U.S. Pat. No. 6,503,381; U.S.
Pat. No. 6,591,125; U.S. Pat. No. 6,616,819; U.S. Pat. No.
6,618,934; U.S. Pat. No. 6,676,816; U.S. Pat. No. 6,749,740; U.S.
Pat. No. 6,893,545; U.S. Pat. No. 6,942,518; U.S. Pat. No.
6,514,718; U.S. Pat. No. 5,264,014; U.S. Pat. No. 5,262,305; U.S.
Pat. No. 5,320,715; U.S. Pat. No. 5,593,852; U.S. Pat. No.
6,746,582; U.S. Pat. No. 6,284,478; U.S. Pat. No. 7,299,082; U.S.
patent application Ser. No. 10/745,878 filed Dec. 26, 2003 entitled
"Continuous Glucose Monitoring System and Methods of Use"; U.S.
Patent Application No. 61/149,639 entitled "Compact On-Body
Physiological Monitoring Device and Methods Thereof", U.S. patent
application Ser. No. 11/461,725, filed Aug. 1, 2006; U.S. Patent
Application Publication No. 2007/0095661; U.S. Patent Application
Publication No. 2006/0091006; U.S. Patent Application Publication
No. 2006/0025662; U.S. Patent Application Publication No.
2008/0267823; U.S. Patent Application Publication No. 2007/0108048;
U.S. Patent Application Publication No. 2008/0102441; U.S. Patent
Application Publication No. 2008/0066305; U.S. Patent Application
Publication No. 2007/0199818; U.S. Patent Application Publication
No. 2008/0148873; and U.S. Patent Application Publication No.
2007/0068807; the disclosures of each which are incorporated by
reference herein.
[0072] In some embodiments, the analyte meter 100 includes a data
storage unit (not shown) operably connected to the controller unit,
e.g., as described in U.S. patent application Ser. No. 11/396,182,
filed Mar. 31, 2006, titled "Analyte Monitoring Devices and Methods
Therefor," the disclosure of which is incorporated by reference
herein.
Dosage Calculation Function
[0073] In some embodiments, the controller unit is configured to
perform medication dosage calculation functions, such as a
single-dose calculation function for injection of rapid acting
insulin and/or long acting insulin. Analyte meters which include
medication dosage calculation functions and methods of performing
the dosage calculation functions are described, for example, in
U.S. patent application Ser. No. 11/396,182, filed Mar. 31, 2006,
titled "Analyte Monitoring Devices and Methods Therefor," the
disclosure of which is incorporated by reference herein.
[0074] In one embodiment, the controller unit is configured to
perform a bolus calculation function. For example, the controller
unit may be configured to determine a bolus dosage, e.g., an
insulin bolus dosage, based on the signal received from the analyte
sensor.
[0075] In one embodiment the controller unit is configured to
perform an algorithm to determine a medication dosage based on a
determined concentration of analyte.
[0076] The analyte meter 100 may be configured to automatically
enter into a medication dosage calculation mode to, for example,
calculate and/or select a medication dosage amount based on
information stored in the analyte meter 100 (such as the patient's
insulin sensitivity, for example), and/or prompt the patient to
provide additional information, such as the amount of carbohydrate
to be ingested by the patient for determination of, for example, a
carbohydrate bolus dosage determination. The patient may operate
the input unit 107 (described in greater below) to provide the
appropriate information.
[0077] In another embodiment, the analyte meter 100 may be
configured to prompt the patient to select whether to retrieve a
predetermined or preprogrammed medication dosage amount such as,
for example, a correction bolus or a carbohydrate bolus, following
the display of the determined analyte concentration from the
analyte sensor 200. In this manner, in one embodiment of the
present disclosure, analyte meter 100 may be configured to
automatically prompt the user or patient to select whether a
medication dosage determination is desired following analyte
testing using the analyte sensor 200.
[0078] FIG. 10 provides a flowchart illustrating an analyte
concentration determination and medication dose calculation
procedure in accordance with one embodiment of the present
disclosure. Referring to FIG. 10 and FIGS. 1-8, an analyte sensor
200 is detected by the analyte meter 100 (510). Thereafter, the
fluid sample, such as a blood sample, present in the measurement
zone of analyte sensor 200 is analyzed (520) to determine the
corresponding analyte level, such as a glucose level, and the
determined analyte level is output (530) on the optional display
unit 108 of analyte meter 100, for example, in units of mg/dL.
[0079] After determining the analyte level and displaying the
measured analyte level to the patient (530), a prompt command is
generated and output to the patient to select if the medication
dosage calculation is desired (540). More specifically, in one
embodiment of the present disclosure, the controller unit is
configured to generate a command and display in the optional
display unit 108 to query the user as to whether a medication
dosage calculation determination is desired by the patient.
Thereafter, a determination of whether or not the patient has
selected to have the medication dosage calculation performed by the
controller unit is made (550). In one embodiment, the patient may
operate the optional input unit 107 to select whether or not to
have the medication dosage calculation performed.
[0080] If it is determined that the patient has selected not to
have the medication dosage determination performed, then the
determined analyte value is displayed and/or stored (560), e.g., in
an optional data storage unit of analyte meter 100, and the routine
terminates. For example, in one embodiment, the controller unit may
be configured to store the determined analyte value in the optional
data storage unit with associated time and/or date information of
when the analyte value determination is performed. In an alternate
embodiment, the measured analyte value may be stored substantially
concurrently with the display of the analyte value.
[0081] On the other hand, if it is determined that the patient has
selected to have the medication dosage calculation performed, the
analyte meter 100 is configured to enter the medication dosage
determination mode (570), described in further detail below in
conjunction with FIG. 11, where the desired type of medication
dosage is determined and provided to the patient.
[0082] FIG. 11 is a flowchart illustrating the medication dose
calculation procedure of FIG. 10 in accordance with one embodiment
of the present disclosure. Referring to FIG. 11 and FIGS. 1-8, when
the analyte meter 100 enters the medication dosage determination
mode as described above, the controller unit is configured to
prompt the patient (for example, by displaying the options to the
patient on the optional display unit 108 to select the type of
desired medication dosage calculation (610). For example, the
controller unit may be configured to output a list of available
medication dosage calculation options including, for example, bolus
calculation options such as a carbohydrate bolus, a correction
bolus, a dual or extended bolus, a square wave bolus, or any other
suitable medication calculation function which may be programmed
into the analyte meter 100 (and for example, stored in the optional
data storage unit).
[0083] After the patient selects the desired medication dosage
calculation in response to the prompt for medication type selection
(610), the selected medication dosage calculation routine is
retrieved (620) from the optional data storage unit, and thereafter
executed (630). In one embodiment, the execution of the selected
medication dosage calculation (630) may include one or more input
prompts to the patient to enter additional information as may be
required to perform the selected medication dosage calculation.
[0084] For example, in the case of calculating a carbohydrate
bolus, the patient may be prompted to provide or enter an estimate
of the carbohydrate amount that the patient is planning on
ingesting. In this regard, a food database may be stored in the
optional data storage unit or elsewhere for easy access (e.g., a
PC, PDA, telephone, or the like and to which the analyte monitor
may be coupled (e.g., wirelessly or by physical connection) to
easily retrieve such information) to conveniently determine the
corresponding carbohydrate amount associated with the type of food
which the patient will be ingesting. Alternatively, the patient may
provide the actual estimated carbohydrate count if such information
is readily available by the patient.
[0085] In the case of calculating a dual bolus of insulin, the
patient is prompted to provide, in addition to a dose amount, a
time duration information for the extended portion of the bolus
dosage to be infused or otherwise delivered to the patient.
Similarly, the patient may further be prompted to provide insulin
sensitivity information, and any other information as may be
necessary to determine the selected bolus dosage amount in
conjunction with other relevant information such as insulin on
board information, and the time of the most recently administered
bolus (so as to provide a warning to the patient if a bolus dosage
has been administered within a predetermined time period, and a
subsequent administration of the additional bolus dosage may
potentially be harmful).
[0086] After the execution of the selected medication dosage
calculation routine (630), the calculated medication dosage amount
is stored (640) in the optional data storage unit, and the
calculated medication dosage amount is output displayed to the
patient (650) on the display unit 108 of the analyte meter 100, or
audibly if the analyte meter is so configured. In certain
embodiments, storing and output displaying the calculated
medication dosage amount may be substantially concurrently
performed, rather than sequentially.
[0087] FIG. 12 is a flowchart illustrating an analyte level
determination and medication dose calculation procedure in
accordance with another embodiment of the present disclosure. An
analyte sensor 200 is inserted into the sensor port 101 of analyte
meter 100 (710), the fluid sample in the measurement zone of
analyte sensor 200 is analyzed to determine the corresponding
analyte concentration (720), and thereafter, output displayed
(730).
[0088] The controller unit is configured to enter into the
medication dosage determination mode, retrieve a programmed or
predetermined bolus calculation routine (740), execute the
pre-programmed or predetermined bolus calculation routine (750),
and thereafter, output display the calculated medication dosage
amount (760). In this manner, in one embodiment of the present
disclosure, the analyte meter 100 may be programmed or configured
to automatically enter into the medication dosage determination
mode upon completion of the fluid sample analysis for analyte level
determination.
[0089] In one embodiment of the present disclosure, the analyte
meter 100 may be configured to execute different types of
medication dosage calculations based on the patient specified
parameters. For example, the analyte meter 100 may be configured to
perform a carbohydrate bolus determination when the analyte sensor
sample analysis is performed within a predetermined time period of
a meal event. For example, the analyte meter 100 may be programmed
by the patient to automatically select the carbohydrate bolus
determination if the analyte sensor fluid sample analysis is
performed within one hour prior to a meal time (which may be
programmed into the analyte meter 100).
Integrated Medication Delivery System
[0090] In some embodiments, analyte meter 100 includes an optional
medication delivery device or system (not shown). Additional
information regarding medication delivery devices or systems, such
as, for example, integrated systems, are provided, for example, in
U.S. Patent Application Publication No. US2006/0224141, published
on Oct. 5, 2006, titled "Method and System for Providing Integrated
Medication Infusion and Analyte Monitoring System", and U.S. Patent
Application Publication No. US2004/0254434, published on Dec. 16,
2004, titled "Glucose Measuring Module and Insulin Pump
Combination," the disclosure of each of which is incorporated by
reference herein. Medication delivery devices which may be provided
with analyte meter 100 include, e.g., a needle, syringe, pump,
catheter, inhaler, transdermal patch, or combination thereof.
[0091] The medication delivery device or system may be in the form
of a drug delivery injection pen such as a pen-type injection
device incorporated within housing 105 of analyte meter 100.
Additional information is provided in U.S. Pat. Nos. 5,536,249 and
5,925,021, the disclosure of each of which is incorporated by
reference herein.
[0092] The medication delivery system may be used for injecting a
dose of medication, such as insulin, into a patient based on a
prescribed medication dosage, and may be automatically updated with
dosage information received from the controller unit (not shown) of
analyte meter 100. In another embodiment, the medication dosage of
the medication delivery system may include manual entry of dosage
changes made through, for example, optional input unit 107 coupled
to the housing of analyte meter 100. Medication dosage information
associated with the medication delivery system may be displayed on
an optional display unit disposed on housing 105 of analyte meter
100.
Analyte Detection Systems
[0093] An analyte meter 100 as described herein can be a component
of one or more analyte detections systems. For example, an analyte
detection system according to the present disclosure can include an
analyte meter 100 as described herein in addition to one or more
sample acquisition and/or testing elements known in the art. In one
embodiment, an analyte detection system according to the present
disclosure includes an analyte sensor, e.g., an analyte sensor 200
as described herein, and a lancet. In some embodiments, the analyte
sensor 200 is in the form of a test strip.
[0094] In some embodiments, a lancet and an analyte sensor 200 in
the form of a test strip are integrated into the housing of the
analyte meter 100. In specific embodiments, a plurality of analyte
sensors and a plurality of lancets are integrated into the housing
of an analyte meter 100. In other embodiments, the lancet and the
test strip are not integrated into the housing of the analyte
meter, but are instead included in the system as separate
components.
[0095] Where the test strip is integrated into the housing of an
analyte meter 100, the housing can be configured to hold one or
more cartridges or magazines containing test strips to be used in
the operation of the system. Similarly, where the lancet is
integrated into the housing of an analyte meter 100, the housing
can be configured to hold one or more cartridges or magazine
containing lancets to be used in the operation of the system.
[0096] Additional systems incorporating the analyte meters
described herein will be readily apparent to those of ordinary
skill in the art upon reading the present disclosure.
Integrated Monitoring Device
[0097] In one embodiment, the analyte meter 100 incorporates an
optional continuous analyte monitoring device, e.g., a continuous
glucose monitoring device (CGM). The continuous analyte monitoring
device can be, e.g., a transcutaneously implanted sensor which
continually or substantially continually measures an analyte
concentration of a bodily fluid. Examples of continuous analyte
monitoring systems and devices are described in U.S. Pat. Nos.
5,356,786; U.S. Pat. No. 6,175,752; U.S. Pat. No. 6,560,471; U.S.
Pat. No. 5,262,035; U.S. Pat. No. 6,881,551; U.S. Pat. No.
6,121,009; U.S. Pat. No. 7,167,818; U.S. Pat. No. 6,270,455; U.S.
Pat. No. 6,161,095; U.S. Pat. No. 5,918,603; U.S. Pat. No.
6,144,837; U.S. Pat. No. 5,601,435; U.S. Pat. No. 5,822,715; U.S.
Pat. No. 5,899,855; U.S. Pat. No. 6,071,391; U.S. Pat. No.
6,120,676; U.S. Pat. No. 6,143,164; U.S. Pat. No. 6,299,757; U.S.
Pat. No. 6,338,790; U.S. Pat. No. 6,377,894; U.S. Pat. No.
6,600,997; U.S. Pat. No. 6,773,671; U.S. Pat. No. 6,514,460; U.S.
Pat. No. 6,592,745; U.S. Pat. No. 5,628,890; U.S. Pat. No.
5,820,551; U.S. Pat. No. 6,736,957; U.S. Pat. No. 4,545,382; U.S.
Pat. No. 4,711,245; U.S. Pat. No. 5,509,410; U.S. Pat. No.
6,540,891; U.S. Pat. No. 6,730,200; U.S. Pat. No. 6,764,581; U.S.
Pat. No. 6,299,757; U.S. Pat. No. 6,461,496; U.S. Pat. No.
6,503,381; U.S. Pat. No. 6,591,125; U.S. Pat. No. 6,616,819; U.S.
Pat. No. 6,618,934; U.S. Pat. No. 6,676,816; U.S. Pat. No.
6,749,740; U.S. Pat. No. 6,893,545; U.S. Pat. No. 6,942,518; U.S.
Pat. No. 6,514,718; U.S. Pat. No. 5,264,014; U.S. Pat. No.
5,262,305; U.S. Pat. No. 5,320,715; U.S. Pat. No. 5,593,852; U.S.
Pat. No. 6,746,582; U.S. Pat. No. 6,284,478; U.S. Pat. No.
7,299,082; U.S. patent application Ser. No. 10/745,878 filed Dec.
26, 2003 entitled "Continuous Glucose Monitoring System and Methods
of Use"; and U.S. Application No. 61/149,639 entitled "Compact
On-Body Physiological Monitoring Device and Methods Thereof", the
disclosures of each which are incorporated by reference herein.
Communication Device
[0098] In some embodiments, the analyte meter 100 includes an
optional communication device (not shown), e.g., a receiver and/or
transmitter for communicating with another device, e.g., a
medication delivery device and/or a patient monitoring device,
e.g., a continuous glucose monitoring device as described above, or
a health management system, such as the CoPilot.TM. system
available from Abbott Diabetes Care Inc., Alameda, Calif.. The
communication device can be configured for wired or wireless
communication, including, but not limited to, radio frequency (RF)
communication, Zigbee communication protocols, WiFi, Bluetooth
communication protocols, and cellular communication, such as code
division multiple access (CDMA) or Global System for Mobile
communications (GSM).
[0099] In one embodiment, analyte meter 100 includes a wireless
communication device, wherein the wireless communication device is
configured for bi-directional radio frequency (RF) communication
with other devices to transmit and/or receive data to and from the
analyte meter 100.
[0100] In one embodiment, the communication device is configured to
include physical ports or interfaces such as a USB port, an RS-232
port, or any other suitable electrical connection port to allow
data communication between the analyte meter 100 and other external
devices such as a computer terminal (for example, at a physician's
office or in hospital environment), an external medical device,
such as an infusion device or including an insulin delivery device,
or other devices that are configured for similar complementary data
communication.
[0101] In one embodiment, the communication device is configured
for infrared communication, Bluetooth communication, or any other
suitable wireless communication mechanism to enable the analyte
meter 100 for communication with other devices such as infusion
devices, analyte monitoring devices, computer terminals and/or
networks, communication enabled mobile telephones, personal digital
assistants, or any other communication devices which the patient or
user of the analyte meter may use in conjunction therewith, in
managing the treatment of a health condition, such as diabetes.
[0102] In one embodiment, the analyte meter is configured to
wirelessly communicate with a server device, e.g., using a common
standard such as 802.11 or Bluetooth RF protocol, or an IrDA
infrared protocol. The server device could be another portable
device, such as a Personal Digital Assistant (PDA) or notebook
computer, or a larger device such as a desktop computer, appliance,
etc. In some embodiments, the server device has a display, such as
a liquid crystal display (LCD), as well as an input device, such as
buttons, a keyboard, mouse or touch-screen. With such an
arrangement, the user can control the meter indirectly by
interacting with the user interface(s) of the server device, which
in turn interacts with the meter across a wireless link.
Input Unit
[0103] In some embodiments, analyte meter 100 includes an optional
input unit 107 coupled to the housing 105. The input unit can be
configured to include one or more input buttons (as shown in FIGS.
1, 3, 5 and 7), a jog wheel, capacitive sensing slider inputs, or
combinations thereof. In one embodiment, a user or patient can
operate the input unit to perform calculations and determinations
associated with one or more medication dose calculation functions,
such as a bolus dose calculation function, of the analyte meter
100.
[0104] In one embodiment, the input unit includes a plurality of
input buttons, wherein each input button is designated for a
specific task. Alternatively, one or more of the input buttons can
be "soft buttons". In the case where one or more of the plurality
of input buttons are "soft buttons", these buttons may be used for
a variety of functions. The variety of functions may be determined
based on the current mode of the analyte meter 100, and may be
distinguishable to a user by the use of button instructions shown
on optional display unit 108 of analyte meter 100. Yet another
input method may be a touch-sensitive display unit, as described in
greater detail below.
[0105] In addition, in some embodiments, the input unit 107 is
configured such that a user can operate input unit 107 to adjust
time and/or date information, as well as other features or settings
associated with the operation of analyte meter 100.
Display
[0106] In some embodiments, the analyte meter 100 includes an
optional display unit 108 or a port (not shown) for coupling an
optional display unit to the analyte meter 100. The display unit
displays the sensor signals and/or results determined from the
sensor signals including, for example, analyte concentration, rate
of change of analyte concentration, and/or the exceeding of a
threshold analyte concentration (indicating, for example, hypo- or
hyperglycemia).
[0107] The display unit 108 can be a dot-matrix display. In other
embodiments, other display types, such as liquid-crystal displays
(LCD), plasma displays, light-emitting diode (LED) displays, or
seven-segment displays, among others, may alternatively be used.
The display unit 108 can be configured to provide, an alphanumeric
display, a graphical display, a video display, an audio display, a
vibratory output, or combinations thereof. The display unit can
also be configured to provide, for example, information related to
a patient's current analyte concentration as well as predictive
analyte concentrations, such as trending information.
[0108] In some embodiments the input unit 107 and the display unit
108 are integrated into a single unit, for example, the display
unit 108 can be configured as a touch sensitive display where the
patient may enter information or commands via the display area
using, for example, a stylus or any other suitable input device,
and where, the touch sensitive display is configured as the user
interface in an icon driven environment, for example.
Additional Functional Units
[0109] A variety of analyte meters are known in the art, many of
which includes additional components and functionalities which can
be readily incorporated into the analyte meters described herein.
Disclosure of such additional components and functionalities can be
found, for example, in U.S. Patent Application Publication No.
2008/0119702, U.S. Patent Application Publication No. US
2008/0114280, and U.S. Patent Application Publication No.
2008/0119710, the disclosure of each of which is incorporated by
reference herein.
Demarcation
[0110] In one embodiment, an analyte meter according to the present
disclosure includes a demarcation that corresponds with a
complementary demarcation on an analyte sensor configured to be
received by the analyte meter. The use of complementary
demarcations on the analyte sensor and meter facilitate insertion
of the analyte sensor into the meter in a particular orientation,
e.g., a correct orientation. In other words, enables correct
registration between an analyte sensor and a meter. A correct
orientation is one in which the analyte meter is capable of
receiving a sensor signal from the analyte sensor, which signal is
indicative of an analyte concentration.
[0111] Suitable demarcations include, e.g., colored areas, visible
designs or patterns, patterns of indentations, patterns of raised
areas, or combinations thereof. The demarcation on the analyte
sensor can be the same as a demarcation on the analyte meter. By
way of example, FIG. 9, panel A, illustrates an embodiment wherein
the top surface of analyte sensor 200 comprises a checkerboard
pattern which corresponds to a matching checkerboard pattern
present on analyte meter 100. FIG. 9, panel B, illustrates a
further embodiment in which analyte sensor 200 and analyte meter
100 have a matching pattern of vertical lines in addition to
matching checkerboard patterns.
[0112] Corresponding demarcations need not be matching. However,
they are configured to convey an insertion orientation to the user.
FIG. 9, panel C, for example, shows corresponding arrow designs
which are similar except that they point in opposite directions
when the analyte sensor is inserted in the intended
orientation.
[0113] In some embodiments, the analyte sensor includes a first
demarcation which includes a first portion of a design or logo, and
the analyte meter includes a second demarcation comprising a second
portion of the design, such that the first portion of the design
mates with the second portion of the design to produce the design
when the sensor is correctly inserted into the analyte meter.
Analytes
[0114] A variety of analytes can be detected and quantified using
the disclosed analyte sensors and meters. Analytes of particular
interest include glucose and lactate. Additional analytes that may
be determined include, for example, acetyl choline, amylase,
bilirubin, cholesterol, chorionic gonadotropin, creatine kinase
(e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine,
growth hormones, hormones, ketones (e.g., ketone bodies), lactate,
oxygen, peroxide, prostate-specific antigen, prothrombin, RNA,
thyroid stimulating hormone, and troponin. The concentration of
drugs, such as, for example, antibiotics (e.g., gentamicin,
vancomycin, and the like), digitoxin, digoxin, drugs of abuse,
theophylline, and warfarin, may also be determined. Assays suitable
for determining the concentration of DNA and/or RNA are disclosed
in U.S. Pat. No. 6,281,006 and U.S. Pat. No. 6,638,716, the
disclosures of each of which are incorporated by reference
herein.
Methods of Using Analyte Meter
[0115] The analyte meters described herein find use in methods for
determining the concentration of an analyte in a fluid sample from
a subject. Generally, these methods include inserting an analyte
sensor into an analyte meter 100; contacting a fluid sample e.g. a
blood sample, with the analyte sensor; generating a sensor signal
at the working electrode; and determining the concentration of the
analyte using the generated sensor signal. Examples of specific
electrochemical reactions which can be utilized to produce a sensor
signal are described in detail in U.S. Pat. No. 6,592,745, the
disclosure of which is incorporated by reference herein.
[0116] In one embodiment, the analyte sensor is an analyte sensor
200 as described herein. However, it is contemplated that analyte
sensors other than those specifically described herein may be
configured to operate with the analyte meters 100 disclosed herein.
Furthermore, analyte meters can be configured as described herein
to be compatible with a variety of analyte sensors.
[0117] In one embodiment, the determining step includes determining
the concentration of the analyte by amperometry, coulometry,
potentiometry, and/or voltametry, including square wave voltametry,
using the analyte sensor.
[0118] In one embodiment, the determining step includes determining
the concentration of the analyte optically. Optical detection of
analyte concentration is described, for example, in U.S. Pat. No.
6,592,745, the disclosure of which is incorporated by reference
herein.
[0119] In one embodiment, the method includes a medication dosage
determination step. For example, where the analyte is glucose, the
method can include a determination step in which the controller
unit performs an algorithm to determine an insulin dose, e.g., a
bolus insulin dose, based on the concentration of glucose in the
sample.
[0120] In another embodiment, the method includes an administering
step wherein a medication dose, e.g., an insulin dose, determined
according to the method is administered to the subject via a
medication delivery device, e.g., a needle, syringe, pump,
catheter, inhaler, transdermal patch, or combination thereof.
[0121] In another embodiment, the administering step includes
administering a medication dose, e.g., an insulin dose, determined
according to the method to the subject via a medication delivery
device positioned at a distance from the analyte meter and in
communication with the analyte meter.
[0122] A medication dose, e.g., a bolus dose, determined according
to the above methods can be displayed to the user via optional
display unit 108 of analyte meter 100.
[0123] As discussed previously herein, analyte sensors 200 and
analyte meters 100 can be configured for orientation non-specific
insertion of the analyte sensor 200 into analyte meter 100. By
orientation non-specific insertion, it is meant that either the
first substrate or the second substrate can be upward facing when
the proximal end of analyte sensor 200 is inserted into the sensor
port of a corresponding analyte meter. That is, either the first
substrate 201 or the second substrate 202 can be upward facing when
the proximal end of the sensor is inserted into analyte meter 100.
As such, during a method of using analyte meter 100 with analyte
sensor 200, the analyte sensor 200 can be inserted in either of the
above orientations without negatively affecting the results of the
assay.
Method for Facilitating the Correct Insertion of an Analyte Sensor
into an Analyte Meter
[0124] The present disclosure provides a method for facilitating
the correct insertion of an analyte sensor into an analyte meter.
In one embodiment, the method includes providing an analyte meter
configured to receive an analyte sensor, wherein the analyte meter
includes a first demarcation. The method also includes providing an
analyte sensor configured for insertion into the analyte meter. The
analyte sensor includes a second demarcation which together with
the first demarcation indicates an insertion orientation for the
analyte sensor.
[0125] The demarcations can include, e.g., a color, a design or
portion thereof, a pattern of indentations, a pattern of raised
areas, or a combination thereof.
[0126] In the embodiment shown in FIG. 9, panel A, for example,
analyte sensor 200 includes a checkerboard pattern on a first face
of analyte sensor 200. This demarcation corresponds to a
checkerboard pattern present on a first face of analyte meter 100.
Together the demarcations indicate an insertion orientation for the
analyte sensor, i.e., checkerboard side up, to a user of the
analyte sensor 200 and analyte meter 100. In this embodiment, the
demarcations provide a Y-axis orientation for insertion of analyte
sensor 200.
[0127] FIG. 9, panel B, shows analyte sensor 200 and analyte meter
100, wherein a first face of analyte sensor 200 includes the
checkerboard pattern of FIG. 9, panel A, and a second face of
analyte sensor 200 includes a pattern of vertical lines. Analyte
meter 100 has a first face which includes a corresponding
checkerboard pattern and a second face which includes a
corresponding pattern of vertical lines. Together the demarcations
indicate an insertion orientation for the analyte sensor, i.e.,
checkerboard side up and vertical lines positioned to the right, to
a user of the analyte sensor 200 and analyte meter 100. In this
embodiment, the demarcations provide an X and Y-axis orientation
for insertion of analyte sensor 200.
[0128] FIG. 9, panel C, shows a third embodiment in which analyte
sensor 200 includes an arrow design positioned on a first face of
analyte sensor 200 towards the proximal end of analyte sensor 200.
Analyte meter 100 includes a corresponding arrow design positioned
on a first face of analyte meter 100. The arrow designs are
positioned such that when analyte sensor 200 is correctly inserted
into analyte meter 100 the tips of the arrows appear to be in
contact when the analyte sensor and meter are viewed from the top.
As with the embodiment of FIG. 9, panel B, the demarcations of this
embodiment provide an X and Y-axis orientation for insertion of
analyte sensor 200.
[0129] While the present invention has been described with
reference to the specific embodiments thereof, it should be
understood by those skilled in the art that various changes may be
made and equivalents may be substituted without departing from the
true spirit and scope of the invention. In addition, many
modifications may be made to adapt a particular situation,
material, composition of matter, process, process step or steps, to
the objective, spirit and scope of the present invention. All such
modifications are intended to be within the scope of the claims
appended hereto.
* * * * *